Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Gastroenterology. 2012 Jan 5;142(4):754–761. doi: 10.1053/j.gastro.2011.12.043

Table 2.

Symptom Related Measures at Follow-Up by Reflux Esophagitis, Normal Histology, and Control Group

Reflux
Esophagitis
(n=50)
Normal
Histology
(n=53)
Controls
(n=142)
p-value
Reflux
vs.
Normal
p-value
Reflux
vs.
Control
p-value
Normal
vs.
Control
Self Reported Outcomes
Acid Suppression Use 31%
(15/49)
13%
(7/53)
4%
(5/142)
<0.05 <0.05 <0.001
Nissen Fundoplication 4%
(2/50)
0%
(0/53)
0%
(0/142)
NA NA NA
Dyspeptic Symptom Severity
  mean ± SD
4.80 ± 3.99 3.96 ± 3.65 1.96 ± 2.25 NS <0.001 <0.001
Abdominal Pain Severity
  mean ± SD
1.16 ± 1.00 1.28 ± 1.02 0.45 ± 0.60 NS <0.001 <0.001

Note: NS= not significant; NA= not applicable; GI= Gastrointestinal